AVITA Medicalの空売り状況は、投資家がAVITA Medicalの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

AVITA Medical (NASDAQ:RCEL) 株価情報, 空売り情報

AVITA Medical

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

AVITA Medical Inc

Scotiabank analyst Jonathan Goldman maintains Toromont Industries (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TIH#TSX">TIH</a>) with a Sector Perform and lowers the price target from C$133.5 to C$128.

News

Price Target

Analyst Ratings

TSX:TIH

Scotiabank Maintains Sector Perform on Toromont Industries, Lowers Price Target to C$128

WIIM

Garrett Motion shares are trading higher after BWS Financial raised its price target on the stock from $12 to $14.

Equinor ASA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) subsidiary, Equinor Brasil Energia, on Thursday, planned to sell its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45156021/equinor-sells-the-peregrino-field-for-usd-3-5-billion" rel="noreferrer noopener">60% operated interest</a> in the Peregrino field in Brazil to Prio Tigris for $3.35 billion.
The payment will be made in two tranches: $2.23 billion (plus a contingent of $166 million upon completion of the second part) for 40% and operatorship, and $951 million for the remaining 20% plus up to $150 million in interest could be added.
The deal&#8217;s effective date is January 1, 2024, with the final cash payment adjusted accordingly.
Equinor will continue to operate the Peregrino field until the transaction Veronica Coelho, Senior Vice President and Country Manager for Equinor Brazil, is finalized, at which point PRIO will assume operatorship.
Philippe Mathieu, Executive Vice President for Exploration and Production International at Equinor, said, &#8220;Brazil will continue to be a core country for Equinor, as we focus on starting up the Bacalhau field and continue progressing the Raia gas project. With these two operated projects and our partnership in Roncador our equity production in Brazil will be close to 200,000 barrels per day by 2030,&#8221;
&#8220;This deal is part of Equinor&#8217;s ongoing effort to high-grade its international portfolio through asset divestments and acquisitions. We continue to see growth potential and opportunities to extend the longevity of our international oil and gas portfolio, also in Brazil,&#8221;
Notably, Equinor has operated the Peregrino heavy oil field since 2009, with approximately 300 million barrels produced to date.
The field, located in the Campos Basin east of Rio de Janeiro, consists of an FPSO and three fixed platforms.
In the first quarter of 2025, Equinor&#8217;s share of production was about 55,000 barrels per day. Last year, PRIO acquired Sinochem&#8217;s 40% stake in Peregrino.
Veronica Coelho, Senior Vice President and Country Manager for Equinor Brazil added, &#8220;We are preparing for operations on Bacalhau, as well as the startup of the Serra da Babilonia renewable hybrid project by our subsidiary Rio Energy and we are progressing the Raia gas project.&#8221;&nbsp;
In April, the company&nbsp;reported&nbsp;first-quarter&nbsp;FY25 revenue and other income rose 19%&nbsp;year-over-year (Y/Y) to&nbsp;$29.92 billion, and adjusted revenue upped 19%&nbsp;Y/Y to&nbsp;$29.60 billion <a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/45113198/why-is-equinor-stock-trading-lower-on-wednesday" rel="noreferrer noopener">vs. consensus estimate of $25.92 billion</a>.
Equinor expects organic capital distributions&nbsp;of&nbsp;around&nbsp;$13 billion&nbsp;in 2025, including <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$9 billion in cash return (buybacks/dividends)</a>.
The company projects oil and gas production growth of about 4% in 2025, while scheduled maintenance activity is estimated to decrease equity production by around 30 mboe per day.
Investors can gain exposure to the stock via&nbsp;Keating Active ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEAT#NASDAQ">KEAT</a>) and&nbsp;The 2023 ETF Series Trust II GMO International Value ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMOI#NYSE">GMOI</a>).
Price Action: EQNR shares are up 3.58% at $23.12 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44141554/equinor-unveils-major-gas-discovery-find-up-to-44m-barrels-of-recoverable-oil-equivalent-in-norwegian-sea" target="_blank" rel="noreferrer noopener">Equinor Unveils Norwegian Sea Discovery, Projects 44M Barrels Of Recoverable Oil Equivalent</a></li>
</ul>
Photo by Andreas Vogel via Shutterstock

Equities

Large Cap

Asset Sales

Movers

EQNR

The 2023 ETF Series Trust II GMO International Value ETF

GMOI

KEAT

Equinor Offloads Major Stake in Brazilian Oil Field In $3.35 Billion Exit

WillScot shares are trading higher after the company reported better-than-expected Q1 financial results.

Benchmark analyst Mike Hickey maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Buy and raises the price target from $71 to $77.

RBLX

Benchmark Maintains Buy on Roblox, Raises Price Target to $77

ALSN

Allison Transmission shares are trading higher after the company reported better-than-expected Q1 EPS results.

Eaton Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) shares are trading lower premarket on Friday after the company reported <a href="https://www.benzinga.com/pressreleases/25/05/b45161328/eaton-reports-record-first-quarter-2025-results-with-accelerating-organic-growth-raises-full-year-" target="_blank" rel="noreferrer noopener">first-quarter 2025 results</a>.
Revenue rose&nbsp;7%&nbsp;year-over-year (Y/Y) to&nbsp;$6.38 billion, beating the consensus of&nbsp;$6.26 billion. Organic sales growth grew 9% Y/Y.
Electrical Americas segment sales rose 12% Y/Y to $3 billion, aided by organic sales growth of 13% Y/Y. Backlog at the end of the quarter rose 6% Y/Y organically.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44361268/eatons-growth-targets-look-achievable-analyst-raises-eps-forecast-for-2026-2027" target="_blank" rel="noreferrer noopener">Eaton&#8217;s Growth Targets Look Achievable, Analyst Raises EPS Forecast For 2026 &amp; 2027</a>
Electrical Global segment sales grew&nbsp;7%&nbsp;Y/Y&nbsp;to&nbsp;$1.6 billion&nbsp;in the quarter. Backlog increased&nbsp;5% Y/Y organically.
Total segment margins reached&nbsp;23.9%, an expansion of 80 basis points Y/Y in the quarter. Adjusted EPS rose&nbsp;13%&nbsp;Y/Y to&nbsp;$2.72,&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$2.71</a>.
Operating cash flow stood at&nbsp;$238&nbsp;million, and free cash flow came in at&nbsp;$91 million&nbsp;in the quarter.
Paulo Ruiz, Eaton president and chief operating officer, said, &#8220;Demand in our end markets continues to drive strong organic growth. As we look ahead, we&#8217;re confident, even amid broader macroeconomic volatility, we&#8217;re prepared to meet that demand with a proven strategy to invest in our businesses, drive operational excellence and continue our path of growth.&#8221;
Guidance: For 2025, Eaton reiterated adjusted EPS<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">&nbsp;of&nbsp;$11.80&nbsp;–&nbsp;$12.20&nbsp;vs.&nbsp;$11.97 consensus estimate</a>.
The company revised its organic growth outlook to 7.5%-9.5% from 7%&nbsp;–&nbsp;9%&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/43398112/eaton-shares-dip-despite-record-q4-margins-and-strong-eps-beat" rel="noreferrer noopener">in the prior year quarter</a>.
For the&nbsp;second quarter, the company expects organic growth of&nbsp;6%-8%&nbsp;and adjusted EPS of&nbsp;$2.85-$2.95, compared to the street view of&nbsp;$2.98.
Investors can gain exposure to the stock via&nbsp;First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRID#NASDAQ">GRID</a>) and TCW Transform Supply Chain ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPP#NYSE">SUPP</a>).
Price Action: ETN shares are down 2.14% at $295.39 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44245475/eaton-strengthens-data-center-strategy-with-14-billion-fibrebond-acquisition" target="_blank" rel="noreferrer noopener">Eaton Strengthens Data Center Strategy With $1.4 Billion Fibrebond Acquisition</a></li>
</ul>
Image: Shutterstock

Earnings

Guidance

First Trust Nasdaq Clean Edge Smart Grid Infrastructure Index Fund

GRID

SUPP

Eaton Sees Q1 Organic Sales Surge 9%, Boosts 2025 Guidance

United States Cellular shares are trading lower after the company reported worse-than-expected Q1 financial results.

Encompass Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) has outperformed the market over the past 5 years by 2.59% on an annualized basis producing an average annual return of 17.21%. Currently, Encompass Health has a market capitalization of $11.70 billion. 
Buying $100 In EHC: If an investor had bought $100 of EHC stock 5 years ago, it would be worth $225.89 today based on a price of $115.94 for EHC at the time of writing.
<h3>Encompass Health's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746197119_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Encompass Health 5 Years Ago Would Be Worth Today

Terex shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued FY25 guidance above estimates.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Stifel analyst Frank Galanti upgraded the rating for FTAI Aviation Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) from Hold to Buy and maintained the price target of $123. FTAI Aviation shares closed at $86.90 on Thursday. <a href="https://www.benzinga.com/quote/ftai/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Nathan Treybeck upgraded iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) from Equal-Weight to Overweight and raised the price target from $104 to $130. iRhythm Technologies shares closed at $108.59 on Thursday. <a href="https://www.benzinga.com/quote/irtc/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying IRTC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="630" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02104328/image-2-9-1024x630.png" alt="" class="wp-image-899330" style="width:679px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02104328/image-2-9-1024x630.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02104328/image-2-9-300x185.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02104328/image-2-9-768x473.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02104328/image-2-9.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45164963/how-to-earn-500-a-month-from-tyson-foods-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Tyson Foods Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Markets

FTAI

IRTC

This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday

Benchmark analyst Mark Palmer downgrades Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from Buy to Hold.

Downgrades

Benchmark Downgrades Block to Hold

Huntsman shares are trading lower after the company reported worse-than-expected Q1 sales results.

Telephone and Data shares are trading lower after the company reported Q1 financial results and missed its adjusted EPS and revenue estimates.

Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) stock fell 6.1% this week to $139.33 despite reporting stronger-than-expected second-quarter results. 
What To Know: The chipmaker posted revenue of $10.84 billion, <a href="https://www.benzinga.com/news/earnings/25/04/45115978/qualcomm-beats-q2-expectations-on-earnings-revenue-ceo-highlights-focus-on-critical-factors-we-can-control">up 15% year-over-year</a>, and non-GAAP earnings per share of $2.85, a 17% increase. Both figures topped analyst estimates, marking Qualcomm&#8217;s eighth consecutive revenue and seventh consecutive EPS beat.
Growth was driven by its QCT segment, with handset sales rising 12% to $6.93 billion, IoT up 27% to $1.58 billion, and automotive revenue surging 59% to $959 million. Licensing revenue remained flat. CEO Cristiano Amon highlighted continued strength across markets and a focus on diversification. 
For the third quarter, Qualcomm guided revenue between $9.9 billion and $10.7 billion and EPS between $2.60 and $2.80, in line with analysts' expectations. 
Despite the strong performance, analysts offered <a href="https://www.benzinga.com/25/05/45150491/qualcomm-stock-drops-after-analysts-lower-price-targets-despite-strong-demand-from-apple-and-samsung">mixed reactions</a>. While Rosenblatt and Benchmark reiterated Buy ratings, the latter lowered its price target amid concerns over normalizing handset demand and macroeconomic uncertainty. 
Still, optimism remains for growth in IoT and automotive, particularly with upcoming launches from partners like Samsung and strong momentum in China's premium Android market.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45164558/us-adds-177000-jobs-in-april-topping-forecasts-as-economy-navigates-tariff-impact">April Jobs Blow Past Expectations, But Tariff Storm May Be Brewing</a>
<h2 class="wp-block-heading">How To Buy QCOM Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Qualcomm&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, QCOM has a 52-week high of $230.63 and a 52-week low of $120.80.

QCOM

Qualcomm (QCOM) Stock Falls 6% This Week Despite Q2 Earnings Beat

Hecla Mining shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.

Benchmark analyst Daniel Kurnos maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Buy and lowers the price target from $178 to $155.

ABNB

Benchmark Maintains Buy on Airbnb, Lowers Price Target to $155

LBTYA

Liberty Global shares are trading lower after the company reported worse-than-expected Q1 EPS results.

Piper Sandler analyst Rob Owens reiterates Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Overweight and lowers the price target from $365 to $300.

Reiteration

TEAM

Piper Sandler Reiterates Overweight on Atlassian, Lowers Price Target to $300

IESC

IES Holdings shares are trading higher after the company reported a year-over-year increase in Q2 financial results.

Health Care

Press Releases

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

AVITA Medical to Host Investor Webinar Briefing

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

General

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

Comments

AVITA Medical

空売り

AVITA Medical (NASDAQ:RCEL) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル